Juliusson G, Abrahamsson J, Lazarevic V, Antunovic P, Derolf Å, Garelius H, et al. Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden. Leukemia. 2017;31:728–31.

Article  CAS  PubMed  Google Scholar 

Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges. Blood Rev. 2019;36:70–87.

Article  PubMed  Google Scholar 

National Cancer Institute. SEER cancer stat facts: acute myeloid leukemia. 2023. https://seer.cancer.gov/statfacts/html/amyl.html.

Extermann M, Artz A, Rebollo MA, Klepin HD, Krug U, Loh KP, et al. Treating acute myelogenous leukemia in patients aged 70 and above: recommendations from the International Society of Geriatric Oncology (SIOG). J Geriatr Oncol. 2024;15:101626.

Article  CAS  PubMed  Google Scholar 

Ringdén O, Boumendil A, Labopin M, Canaani J, Beelen D, Ehninger G, et al. Outcome of allogeneic hematopoietic stem cell transplantation in patients age >69 years with acute myelogenous leukemia: on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2019;25:1975–83.

Article  PubMed  Google Scholar 

Maakaron JE, Zhang MJ, Chen K, Abhyankar S, Bhatt VR, Chhabra S, et al. Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis. Bone Marrow Transplant. 2022;57:911–7.

Article  PubMed  PubMed Central  Google Scholar 

Maffini E, Ngoya M, Galimard JE, Harbi S, Kröger N, Platzbecker U, et al. Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2023;58:1033–41.

Article  CAS  PubMed  Google Scholar 

Lin RJ, Artz AS. Allogeneic hematopoietic cell transplantation for older patients. Hematol Am Soc Hematol Educ Program. 2021;2021:254–63.

Article  Google Scholar 

Weller JF, Lengerke C, Finke J, Schetelig J, Platzbecker U, Einsele H, et al. Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study. Haematologica. 2024;109:431–43.

Article  CAS  PubMed  Google Scholar 

Walter RB, Potter V, Craddock C. Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Adults over 70 years old. Blood. 2024:blood.2024024247. https://doi.org/10.1182/blood.2024024247. Online ahead of print.

Bhatt VR, Chen B, Gyawali B, Lee SJ. Socioeconomic and health system factors associated with lower utilization of hematopoietic cell transplantation in older patients with acute myeloid leukemia. Bone Marrow Transplant. 2018;53:1288–94.

Article  CAS  PubMed  Google Scholar 

Flannelly C, Tan BE, Tan JL, McHugh CM, Sanapala C, Lagu T, et al. Barriers to hematopoietic cell transplantation for adults in the United States: a systematic review with a focus on age. Biol Blood Marrow Transplant. 2020;26:2335–45.

Article  PubMed  PubMed Central  Google Scholar 

Mishra A, Preussler JM, Bhatt VR, Bredeson C, Chhabra S, D’Souza A, et al. Breaking the age barrier: physicians’ perceptions of candidacy for allogeneic hematopoietic cell transplantation in older adults. Transplant Cell Ther. 2021;27:617.e611–617.

Article  Google Scholar 

Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Döhner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345–77.

Article  PubMed  Google Scholar 

Paras G, Morsink LM, Othus M, Milano F, Sandmaier BM, Zarling LC, et al. Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML. Blood. 2022;139:1694–706.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rodríguez-Arbolí E, Othus M, Orvain C, Zarling LC, Sandmaier BM, Milano F, et al. Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation. Haematologica. 2023;108:273–7.

Article  PubMed  Google Scholar 

Scott BL, Pasquini MC, Logan BR, Wu J, Devine SM, Porter DL, et al. Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes. J Clin Oncol. 2017;35:1154–61.

Article  PubMed  PubMed Central  Google Scholar 

Scott BL, Pasquini MC, Fei M, Fraser R, Wu J, Devine SM, et al. Myeloablative versus reduced-intensity conditioning for hematopoietic cell transplantation in acute myelogenous leukemia and myelodysplastic syndromes-long-term follow-up of the BMT CTN 0901 clinical trial. Transplant Cell Ther. 2021;27:483.e481–486.

Article  Google Scholar 

Blaise D, Tabrizi R, Boher JM, Le Corroller-Soriano AG, Bay JO, Fegueux N, et al. Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation: prospective clinical and socioeconomic evaluation. Cancer. 2013;119:602–11.

Article  CAS  PubMed  Google Scholar 

Heinicke T, Labopin M, Polge E, Niederwieser D, Platzbecker U, Sengelov H, et al. Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (>/=60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT. Bone Marrow Transplant. 2020;55:729–39.

Article  CAS  PubMed  Google Scholar 

Walter RB, Sandmaier BM, Othus M, Orvain C, Rodríguez-Arbolí E, Oshima MU, et al. Comparison of reduced intensity and nonmyeloablative conditioning for adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation in first or second remission. Bone Marrow Transplant. 2023;58:377–85.

Article  PubMed  Google Scholar